Cargando…
Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
Aberrant transforming growth factor-β (TGF-β) plays an important role in the development of cancer such as tumor metastasis and invasion. TGF-β-responsive gene signature is highly activated in chemotherapy-treated triple negative breast cancer (TNBC). Here, we investigated the effect of zerumbone (Z...
Autores principales: | Kim, Sangmin, Lee, Jeongmin, Jeon, Myeongjin, Lee, Jeong Eon, Nam, Seok Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811479/ https://www.ncbi.nlm.nih.gov/pubmed/26637807 |
Ejemplares similares
-
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
por: Jeon, Myeongjin, et al.
Publicado: (2016) -
Celastrol attenuates the inflammatory response by inhibiting IL-1β expression in triple-negative breast cancer cells
por: You, Daeun, et al.
Publicado: (2021) -
Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer
por: Lee, Eun-Hee, et al.
Publicado: (2017) -
Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2015) -
Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity
por: Sarkar, Susobhan, et al.
Publicado: (2018)